Whoops...seems like @Ousia was pretty much spot on hindsight is a wonderful thing @noddy
"By my rough calcs, RFX will have around $4mill in cash when the Zcell finally hits the retail market next year, and RFX management will need to use the 'good news' of finally having Zcells available for retail sale to immediately announce another emergency $12mill+ capital raising. So shareholders should prepare themselves for another year of hefty losses, hefty cash burn, and another year of hefty dilution (will the next raising be done at 10c?). Looking ahead 12 months, RFX's survival depends largely on the deep pockets of Hackett. If he decides to stop financing the company (he will probably have to underwrite the next capital raising if it is to be successful), it will go into administration pretty quickly IMO. Will low Zcell sales/demand prompt Hackett to cut his losses and pull the plug?"
- Forums
- ASX - By Stock
- RFX
- why Redflow is in trouble
why Redflow is in trouble, page-65
Featured News
Add RFX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.63M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RFX (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online